Business
Wanda Awarded Two Patents
Wanda Awarded Two Patents.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 0261Z NetScientific PLC 12 December 2017 \n\nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \nWanda is awarded two patents which increase its ability to detect adverse event scenarios for patients\n \nLondon, UK - December 12th 2017 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the U.S. Patent and Trademark Office of two new patents exclusively licensed to its portfolio company, Wanda. The patents will significantly extend protection for the core technology used in Wanda's software application for remote health and patient management. The patents, titled, \"Apparatus, System, and Method for Detecting Activities and Anomalies in Time Series Data\" and \"Efficient Searching of Stationary Datasets\" are the result of research on clinical time-series data at UCLA.\n \nCommenting on the news, NetScientific's Chief Executive Officer and Chairman of Wanda, Francois R. Martelet said: \"We are delighted to announce that Wanda is further strengthening its IP, an important step in its continued corporate development. We believe Wanda's class-leading predictive and behavioural analytics platform acts as a competitive differentiator in the emerging and highly exciting Digital Health sector.\"\n \nNetScientific holds a 61% stake on a fully diluted basis in Wanda.\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott Jessica Hodgson /\n Chris Welsh / Laura Thornton \n \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n\n\n Tel: +44 (0) 20 7710 7600\n\n\n\n\n \n \nAbout NetScientific \n \nNetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net\n \n \n...